Albireo Pharma, Inc.

Albireo Pharma, Inc.

ALBO
Albireo Pharma, Inc.US flagNASDAQ Capital Market
44.15
USD
- -
- -
915.89MMarket Cap

Albireo Pharma, Inc. (ALBO) Stock Split History

Learn about Albireo Pharma, Inc.'s most recent 1-for-30 basis stock split on November 04, 2016. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Albireo Pharma, Inc.'s most recent stock split

Split Date: 2016-11-04
Split Ratio: 1:30
Price Before Split: $0.49
Price After Split: $0.02

Developer API

Get ALBO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ALBO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 30.00 times fewer shares (a 1:30 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Albireo Pharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2016-11-041:30Yes$0.49$0.02
2012-06-121:4YesN/AN/A

About Albireo Pharma, Inc.

Company overview and industry information

Albireo Pharma, Inc. (ALBO) operates in the Biotechnology industry. The recent 1-for-30 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Albireo Pharma, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.